These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11136646)

  • 21. Valproate-induced hyperammonemia in the psychiatric setting: 2 cases.
    Panikkar GP; Gilman SM
    J Clin Psychiatry; 1999 Aug; 60(8):557-9. PubMed ID: 10485644
    [No Abstract]   [Full Text] [Related]  

  • 22. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study.
    Allarakhia IN; Garofalo EA; Komarynski MA; Robertson PL
    Pediatr Neurol; 1996 May; 14(4):303-7. PubMed ID: 8805173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyperammonia, hypoglycemia and thrombocytopenia in a newborn after materanl treatment with valproate].
    Bruel H; Chabrolle JP; Amusini P; Levesque L; Iskandar K; Poinsot J
    Arch Pediatr; 2001 Apr; 8(4):446-7. PubMed ID: 11339140
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk.
    Tohen M; Castillo J; Baldessarini RJ; Zarate C; Kando JC
    Am J Psychiatry; 1995 Mar; 152(3):413-8. PubMed ID: 7864268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 26. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital.
    Conley EL; Coley KC; Pollock BG; Dapos SV; Maxwell R; Branch RA
    Pharmacotherapy; 2001 Nov; 21(11):1325-30. PubMed ID: 11714204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the occurrence of thrombocytopenia from free valproate levels: A prospective study.
    Nasreddine W; Atweh SF; Beydoun AA; Dirani M; Nawfal O; Beydoun A
    Seizure; 2022 Jan; 94():33-38. PubMed ID: 34864249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproate-associated dysmyelopoiesis in elderly patients.
    So CC; Wong KF
    Am J Clin Pathol; 2002 Aug; 118(2):225-8. PubMed ID: 12162682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate-associated coagulopathies in children during short-term treatment.
    Köse G; Arhan E; Unal B; Ozaydin E; Guven A; Sayli TR
    J Child Neurol; 2009 Dec; 24(12):1493-8. PubMed ID: 19482838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid and immune thrombocytopenia.
    Barr RD; Copeland SA; Stockwell ML; Morris N; Kelton JC
    Arch Dis Child; 1982 Sep; 57(9):681-4. PubMed ID: 6812506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic drug monitoring of valproate].
    Bentué-Ferrer D; Tribut O; Verdier MC;
    Therapie; 2010; 65(3):233-40. PubMed ID: 20699076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium valproate: its use in primary psychiatric disorders.
    McElroy SL; Keck PE; Pope HG
    J Clin Psychopharmacol; 1987 Feb; 7(1):16-24. PubMed ID: 3102563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of valproate across the ages. Treatment of epilepsy in adults.
    Ben-Menachem E; Schmitz B; Tomson T; Vajda F
    Acta Neurol Scand Suppl; 2006; 184():14-27. PubMed ID: 16776493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents.
    Rahman A; Mican LM; Fischer C; Campbell AH
    Ann Pharmacother; 2009 May; 43(5):822-30. PubMed ID: 19401471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematologic toxicity of sodium valproate.
    Acharya S; Bussel JB
    J Pediatr Hematol Oncol; 2000; 22(1):62-5. PubMed ID: 10695824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium valproate and thrombocytopenia.
    Miyake S; Honda K; Kimura S; Ike Y
    Brain Dev; 1979; 1(4):319-22. PubMed ID: 121951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Agranulocytosis and simultaneous cholestatic jaundice induced by sodium valproate in an elderly woman].
    Védrine L; Biance N; Souleau B; Nedellec G; de Revel T
    Presse Med; 2001 Oct; 30(28):1404. PubMed ID: 11688206
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of long-term valproic acid treatment on hematological and biochemical parameters in adolescent psychiatric inpatients: a retrospective naturalistic study.
    Amitai M; Sachs E; Zivony A; Remez R; Ben Baruch R; Amit BH; Kronenberg S; Apter A; Shoval G; Weizman A; Zalsman G
    Int Clin Psychopharmacol; 2015 Sep; 30(5):241-8. PubMed ID: 26020713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.